"El Hospital Quirónsalud Infanta Luisa es, actualmente, uno de los hospitales privados más modernos de Andalucía. Ofrece el mejor servicio médico y de confianza a sus pacientes. El hospital cuenta con una amplia de cartera de servicios y más de 600 profesionales de gran prestigio que se encuentran integrados en una extensa familia. Con una arquitectura avanzada e innovadora y unas instalaciones modernas que buscan la comodidad de los pacientes y sus familias. Además, contamos con cinco centros médicos repartidos por los barrios de la Alameda, Nervión, Los Remedios y uno en Mairena del Aljarafe, así como dos centros de consultas externas anexos al hospital, que suponen en total más de 70 consultas médicas con más de 50 especialidades."

During the past decade, Hospital Quironsalud Infanta Luisa conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 25 clinical trials were completed, i.e. on average, 56.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 20 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Quironsalud Infanta Luisa" #1 sponsor was "Eli Lilly and Company" with 15 trials, followed by "Pfizer" with 12 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Horizon Therapeutics Ireland DAC" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Quironsalud Infanta Luisa" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "AKRN Scientific Consulting, S.L." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Quironsalud Infanta Luisa" are "Rheumatoid Arthritis" (10 trials), "Arthritis, Psoriatic" (6 trials), "Systemic Lupus Erythematosus" (6 trials), "Psoriatic Arthritis" (3 trials) and "Type 2 Diabetes" (3 trials). Many other conditions were trialed in "Hospital Quironsalud Infanta Luisa" in a lesser frequency.

Most popular intervention types in "Hospital Quironsalud Infanta Luisa" are "Drug" (44 trials), "Biological" (4 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Guselkumab" (5 trials), "Tirzepatide" (5 trials), "Baricitinib" (4 trials) and "Adalimumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Quironsalud Infanta Luisa" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Quironsalud Infanta Luisa". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Hospital Quironsalud Infanta Luisa, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Quironsalud Infanta Luisa, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".